JP2015506673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506673A5 JP2015506673A5 JP2014546024A JP2014546024A JP2015506673A5 JP 2015506673 A5 JP2015506673 A5 JP 2015506673A5 JP 2014546024 A JP2014546024 A JP 2014546024A JP 2014546024 A JP2014546024 A JP 2014546024A JP 2015506673 A5 JP2015506673 A5 JP 2015506673A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- molecule encoding
- cell
- rna molecule
- rna molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 16
- 210000004027 cell Anatomy 0.000 claims 14
- 230000008672 reprogramming Effects 0.000 claims 7
- 102000009027 Albumins Human genes 0.000 claims 5
- 108010088751 Albumins Proteins 0.000 claims 5
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims 4
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 claims 4
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 2
- ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical group O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 claims 2
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 102100037362 Fibronectin Human genes 0.000 claims 2
- 108010067306 Fibronectins Proteins 0.000 claims 2
- 108700021430 Kruppel-Like Factor 4 Proteins 0.000 claims 2
- 108010085895 Laminin Proteins 0.000 claims 2
- 102000007547 Laminin Human genes 0.000 claims 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims 2
- 101710135898 Myc proto-oncogene protein Proteins 0.000 claims 2
- 102000009092 Proto-Oncogene Proteins c-myc Human genes 0.000 claims 2
- 108010087705 Proto-Oncogene Proteins c-myc Proteins 0.000 claims 2
- 101710150448 Transcriptional regulator Myc Proteins 0.000 claims 2
- 108010031318 Vitronectin Proteins 0.000 claims 2
- 102100035140 Vitronectin Human genes 0.000 claims 2
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 claims 2
- 239000003610 charcoal Substances 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000003456 ion exchange resin Substances 0.000 claims 2
- 229920003303 ion-exchange polymer Polymers 0.000 claims 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims 2
- 108010055896 polyornithine Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 claims 2
- 210000004927 skin cell Anatomy 0.000 claims 2
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 claims 2
- 238000001890 transfection Methods 0.000 claims 2
- 108091023040 Transcription factor Proteins 0.000 claims 1
- 102000040945 Transcription factor Human genes 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566948P | 2011-12-05 | 2011-12-05 | |
| US61/566,948 | 2011-12-05 | ||
| US201161569595P | 2011-12-12 | 2011-12-12 | |
| US61/569,595 | 2011-12-12 | ||
| US201261637570P | 2012-04-24 | 2012-04-24 | |
| US61/637,570 | 2012-04-24 | ||
| US13/465,490 US8497124B2 (en) | 2011-12-05 | 2012-05-07 | Methods and products for reprogramming cells to a less differentiated state |
| US13/465,490 | 2012-05-07 | ||
| US201261664494P | 2012-06-26 | 2012-06-26 | |
| US61/664,494 | 2012-06-26 | ||
| PCT/US2012/067966 WO2013086008A1 (en) | 2011-12-05 | 2012-12-05 | Methods and products for transfecting cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016213019A Division JP6294944B2 (ja) | 2011-12-05 | 2016-10-31 | 細胞に形質移入するための方法および製品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506673A JP2015506673A (ja) | 2015-03-05 |
| JP2015506673A5 true JP2015506673A5 (cg-RX-API-DMAC7.html) | 2016-01-28 |
| JP6073916B2 JP6073916B2 (ja) | 2017-02-01 |
Family
ID=48574831
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014546024A Active JP6073916B2 (ja) | 2011-12-05 | 2012-12-05 | 細胞に形質移入するための方法および製品 |
| JP2016213019A Active JP6294944B2 (ja) | 2011-12-05 | 2016-10-31 | 細胞に形質移入するための方法および製品 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016213019A Active JP6294944B2 (ja) | 2011-12-05 | 2016-10-31 | 細胞に形質移入するための方法および製品 |
Country Status (12)
| Country | Link |
|---|---|
| US (17) | US9422577B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP2788033B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6073916B2 (cg-RX-API-DMAC7.html) |
| KR (5) | KR20250035015A (cg-RX-API-DMAC7.html) |
| CN (2) | CN111893140A (cg-RX-API-DMAC7.html) |
| AU (7) | AU2012347919B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014013664A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2858148C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3260140T3 (cg-RX-API-DMAC7.html) |
| MX (5) | MX354995B (cg-RX-API-DMAC7.html) |
| RU (3) | RU2624139C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013086008A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| ES3005233T3 (en) | 2010-10-01 | 2025-03-14 | Modernatx Inc | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| EP2683812A4 (en) * | 2011-03-07 | 2014-12-03 | Massachusetts Inst Technology | METHOD FOR CELL TRANSFECTION WITH NUCLEIC ACIDS |
| DE12722942T1 (de) | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| RU2648950C2 (ru) | 2011-10-03 | 2018-04-02 | Модерна Терапьютикс, Инк. | Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение |
| US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| KR20250035015A (ko) | 2011-12-05 | 2025-03-11 | 팩터 바이오사이언스 인크. | 세포를 형질감염시키는 방법들 및 생성물들 |
| AU2012352180A1 (en) | 2011-12-16 | 2014-07-31 | Moderna Therapeutics, Inc. | Modified nucleoside, nucleotide, and nucleic acid compositions |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| EP2855666B1 (en) | 2012-05-25 | 2019-12-04 | Cellectis | Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells |
| BR122019025681B1 (pt) * | 2012-11-01 | 2023-04-18 | Factor Bioscience Inc | Método para inserir uma sequência de ácido nucleico em uma localização segura de um genoma de uma célula |
| HRP20220607T1 (hr) | 2012-11-26 | 2022-06-24 | Modernatx, Inc. | Terminalno modificirana rna |
| ES3047667T3 (en) | 2013-02-22 | 2025-12-04 | Univ Leland Stanford Junior | Methods relating to telomere extension |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| EP3052106A4 (en) | 2013-09-30 | 2017-07-19 | ModernaTX, Inc. | Polynucleotides encoding immune modulating polypeptides |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| MX372651B (es) * | 2014-01-31 | 2020-06-16 | Factor Bioscience Inc | ARN SINTÉTICO PARA SU Uso EN EL TRATAMIENTO DE LA EPIDERMÓLISIS AMPOLLOSA DISTRÓFICA. |
| US20180042969A1 (en) * | 2014-08-07 | 2018-02-15 | Duke University | Compositions and methods for the reprogramming of cells into cardiomyocytes |
| US20170327791A1 (en) * | 2014-11-14 | 2017-11-16 | Jcr Pharmaceuticals Co., Ltd | Muscular dystrophy therapeutic agent containing pluripotent stem cells derived from dental pulp |
| JP7199809B2 (ja) * | 2015-02-13 | 2023-01-06 | ファクター バイオサイエンス インコーポレイテッド | 核酸製品及びその投与方法 |
| EP3286300B1 (en) | 2015-04-24 | 2020-10-21 | University of Copenhagen | Isolation of bona fide pancreatic progenitor cells |
| WO2017053729A1 (en) | 2015-09-25 | 2017-03-30 | The Board Of Trustees Of The Leland Stanford Junior University | Nuclease-mediated genome editing of primary cells and enrichment thereof |
| CA3011692A1 (en) | 2015-11-23 | 2017-06-01 | The Regents Of The University Of Colorado, A Body Corporate | Methods and compositions for reprogramming cells |
| EP3500585A4 (en) | 2016-08-17 | 2020-04-01 | Factor Bioscience Inc. | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION |
| US20190352604A1 (en) * | 2017-02-24 | 2019-11-21 | Koji Tanabe | Nerve cell production method |
| CN106967686B (zh) * | 2017-03-31 | 2019-11-08 | 北昊干细胞与再生医学研究院有限公司 | 软骨细胞体外端粒延长增殖培养的方法及人源组织工程化再生软骨 |
| CN108728903A (zh) * | 2017-04-21 | 2018-11-02 | 深圳市乐土精准医疗科技有限公司 | 基于高通量测序用于地中海贫血大样本筛查的建库方法 |
| AU2018291041B2 (en) * | 2017-06-30 | 2021-08-05 | Inscripta, Inc. | Automated cell processing methods, modules, instruments, and systems |
| CN109280701A (zh) * | 2017-07-21 | 2019-01-29 | 深圳华大基因股份有限公司 | 用于地中海贫血检测的探针、基因芯片及制备方法和应用 |
| WO2019068022A1 (en) * | 2017-09-30 | 2019-04-04 | Inscripta, Inc. | CONTINUOUS FLOW ELECTROPORATION INSTRUMENTATION |
| CA2983845C (en) | 2017-10-26 | 2024-01-30 | University Of Copenhagen | Generation of glucose-responsive beta cells |
| CN108103027B (zh) * | 2018-02-02 | 2021-12-24 | 中国医学科学院血液病医院（血液学研究所） | 高效率血细胞重编程同时实现基因编辑的方法 |
| CN112368368B (zh) * | 2018-06-15 | 2024-01-30 | 扶桑药品工业株式会社 | 辅助生殖医疗用培养基 |
| CN114450265B (zh) | 2019-07-03 | 2024-12-24 | 菲克特生物科学股份有限公司 | 阳离子脂质及其用途 |
| RU2746162C2 (ru) * | 2019-07-30 | 2021-04-08 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Способ трансфекции и культивирования клеток, синтезирующих рекомбинантный белок глутаматдекарбоксилазу |
| US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
| EP4010481A4 (en) | 2019-08-09 | 2023-09-20 | Nutcracker Therapeutics, Inc. | MICROFLUIDIC DEVICE AND METHODS OF USE |
| WO2021231549A2 (en) * | 2020-05-12 | 2021-11-18 | Factor Bioscience Inc. | Engineered gene-editing proteins |
| SE544701C2 (en) * | 2020-12-17 | 2022-10-18 | Cellink Bioprinting Ab | A biodispensing or bioprinting system comprising an apparatus for handling a sample container having a lid |
| WO2025049594A1 (en) * | 2023-08-28 | 2025-03-06 | Ohio State Innovation Foundation | Compositions and methods for reprogramming somatic cells |
Family Cites Families (122)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2705230A (en) * | 1949-09-23 | 1955-03-29 | Allen F Reid | Method of purifying albumin |
| US3539465A (en) | 1968-10-08 | 1970-11-10 | Ncr Co | Encapsulation of hydrophilic liquid-in-oil emulsions |
| FR2322871A1 (fr) * | 1975-09-08 | 1977-04-01 | New Zealand Inventions Dev | Procede d'isolement d'albumine |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| AT403989B (de) * | 1996-09-16 | 1998-07-27 | Immuno Ag | Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels |
| AU5734998A (en) | 1997-01-10 | 1998-08-03 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| GB9703554D0 (en) | 1997-02-20 | 1997-04-09 | Dow Corning | Polymerisation of cyclosiloxanes |
| WO1999014346A2 (en) | 1997-09-19 | 1999-03-25 | Sequitur, Inc. | SENSE mRNA THERAPY |
| GB9827085D0 (en) | 1998-12-09 | 1999-02-03 | Dow Corning | Polymerisation of siloxanes |
| GB9827036D0 (en) | 1998-12-09 | 1999-02-03 | Dow Corning | Polymerisation of siloxanes |
| GB9827069D0 (en) | 1998-12-09 | 1999-02-03 | Dow Corning | Polymerisation catalyst |
| GB9902000D0 (en) * | 1999-01-30 | 1999-03-17 | Delta Biotechnology Ltd | Process |
| US7621606B2 (en) | 2001-08-27 | 2009-11-24 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| DE60132471T2 (de) | 2000-09-26 | 2009-01-15 | Idera Pharmaceuticals, Inc., Cambridge | Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen |
| WO2003027277A1 (en) | 2001-09-21 | 2003-04-03 | Japan Science And Technology Corporation | Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| WO2003033697A1 (en) | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| US7276489B2 (en) | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| GB0202149D0 (en) | 2002-01-30 | 2002-03-20 | Univ Edinburgh | Pluripotency determining factors and uses thereof |
| GB0202633D0 (en) * | 2002-02-05 | 2002-03-20 | Delta Biotechnology Ltd | Stabilization of protein preparations |
| US7541344B2 (en) | 2003-06-03 | 2009-06-02 | Eli Lilly And Company | Modulation of survivin expression |
| US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
| MX2007002390A (es) | 2004-09-08 | 2007-04-23 | Wisconsin Alumni Res Found | Medio y cultivo de celulas progenitoras embrionarias. |
| CA2579652A1 (en) | 2004-09-08 | 2006-03-16 | Wisconsin Alumni Research Foundation | Culturing human embryonic stem cells |
| AU2006269884A1 (en) * | 2005-07-15 | 2007-01-25 | Primegen Biotech, Llc | Therapeutic reprogramming of germ line stem cells |
| SG10201508995QA (en) | 2005-07-26 | 2015-11-27 | Sangamo Biosciences Inc | Targeted integration and expression of exogenous nucleic acid sequences |
| US8323666B2 (en) | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
| EP4174179B1 (en) | 2005-08-23 | 2025-05-07 | The Trustees of the University of Pennsylvania | Rna containing modified nucleosides and methods of use thereof |
| US9012219B2 (en) * | 2005-08-23 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | RNA preparations comprising purified modified RNA for reprogramming cells |
| WO2007026353A2 (en) | 2005-08-29 | 2007-03-08 | Technion Research & Development Foundation Ltd. | Media for culturing stem cells |
| ATE552334T1 (de) * | 2005-09-13 | 2012-04-15 | Takara Bio Inc | Serumfreies medium zur herstellung von retroviralen vektoren |
| AU2006325975B2 (en) * | 2005-12-13 | 2011-12-08 | Kyoto University | Nuclear reprogramming factor |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
| EP1966239A1 (de) | 2005-12-22 | 2008-09-10 | CSL Behring GmbH | Oktanoatreduziertes human albumin |
| KR20080097226A (ko) | 2006-02-24 | 2008-11-04 | 리라이언스 라이프 사이언시스 프라이빗. 리미티드 | 결막 조직 시스템 |
| US20090014055A1 (en) | 2006-03-18 | 2009-01-15 | Solyndra, Inc. | Photovoltaic Modules Having a Filling Material |
| DE102006051516A1 (de) | 2006-10-31 | 2008-05-08 | Curevac Gmbh | (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins |
| GB0623635D0 (en) | 2006-11-27 | 2007-01-03 | Stem Cell Sciences Uk Ltd | Pluripotent cell growth media |
| US10829733B2 (en) | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| JP2010515464A (ja) * | 2007-01-11 | 2010-05-13 | イエール・ユニバーシテイ | Ｈｉｖ細胞表面受容体の標的化不活性化のための組成物および方法 |
| WO2008097926A2 (en) | 2007-02-02 | 2008-08-14 | Yale University | Transient transfection with rna |
| US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
| DK3399025T3 (da) | 2007-03-23 | 2025-06-16 | Wisconsin Alumni Res Found | Omprogrammering af somatiske celler |
| CA2683056C (en) | 2007-04-07 | 2020-03-24 | Whitehead Institute For Biomedical Research | Reprogramming of somatic cells |
| JP2010528613A (ja) * | 2007-05-29 | 2010-08-26 | クリストファー ビー． リード， | 多能細胞集団を産生する方法およびその使用 |
| JP2008307007A (ja) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
| US20090180996A1 (en) * | 2007-11-09 | 2009-07-16 | Zeki Beyhan | Epigenetic modification of cell phenotype, fate and/or function by RNA transfer |
| JP5558097B2 (ja) | 2007-12-10 | 2014-07-23 | 国立大学法人京都大学 | 効率的な核初期化方法 |
| EP2072618A1 (en) * | 2007-12-14 | 2009-06-24 | Johannes Gutenberg-Universität Mainz | Use of RNA for reprogramming somatic cells |
| WO2009117439A2 (en) | 2008-03-17 | 2009-09-24 | The Scripps Research Institute | Combined chemical and genetic approaches for generation of induced pluripotent stem cells |
| CN103203210A (zh) | 2008-03-27 | 2013-07-17 | 哈佛学院院长等 | 基于纸的细胞阵列 |
| US20110045001A1 (en) | 2008-03-28 | 2011-02-24 | Biontex Laboratories Gmbh | Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| EP2275531B1 (en) * | 2008-03-31 | 2015-12-23 | Oriental Yeast Co., Ltd. | Method for proliferation of pluripotent stem cells |
| CN101550406B (zh) * | 2008-04-03 | 2016-02-10 | 北京大学 | 制备多潜能干细胞的方法,试剂盒及用途 |
| WO2009127230A1 (en) | 2008-04-16 | 2009-10-22 | Curevac Gmbh | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION |
| JP2011160661A (ja) * | 2008-06-02 | 2011-08-25 | Kyowa Hakko Kirin Co Ltd | 血球細胞の初期化法 |
| EP3447128A1 (en) | 2008-06-04 | 2019-02-27 | FUJIFILM Cellular Dynamics, Inc. | Methods for the production of ips cells using non-viral approach |
| GB2460552B (en) | 2008-06-05 | 2011-09-07 | Iti Scotland Ltd | Stem cell culture media and methods |
| US8669048B2 (en) | 2008-06-24 | 2014-03-11 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
| US20100184033A1 (en) | 2008-07-16 | 2010-07-22 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
| US20110263015A1 (en) | 2008-08-20 | 2011-10-27 | Virxsys Corporation | Compositions and methods for generation of pluripotent stem cells |
| US20100076057A1 (en) * | 2008-09-23 | 2010-03-25 | Northwestern University | TARGET DNA INTERFERENCE WITH crRNA |
| EP3450545B1 (en) | 2008-10-24 | 2023-08-23 | Wisconsin Alumni Research Foundation | Pluripotent stem cells obtained by non-viral reprogramming |
| ES2561949T3 (es) | 2008-11-21 | 2016-03-01 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Reprogramación de células hacia un estado pluripotente |
| WO2010065123A1 (en) * | 2008-12-04 | 2010-06-10 | Sangamo Biosciences, Inc. | Genome editing in rats using zinc-finger nucleases |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| EP2206723A1 (en) | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| WO2010093655A2 (en) | 2009-02-10 | 2010-08-19 | University Of Dayton | Enhanced method for producing stem-like cells from somatic cells |
| US10894944B2 (en) * | 2009-04-10 | 2021-01-19 | Monash University | Cell culture media |
| US20100273220A1 (en) | 2009-04-22 | 2010-10-28 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
| ES2849181T3 (es) | 2009-04-22 | 2021-08-16 | Viacyte Inc | Composiciones celulares derivadas de células reprogramadas desdiferenciadas |
| US10837020B2 (en) | 2009-04-22 | 2020-11-17 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long RNA molecules |
| EP2424877A4 (en) | 2009-04-28 | 2013-01-02 | Harvard College | SUPRAGELADENE PROTEINS FOR CELL PENETRATION |
| US8496941B2 (en) | 2009-06-03 | 2013-07-30 | National Institute Of Advanced Industrial Science And Technology | Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
| JP2013500018A (ja) | 2009-07-24 | 2013-01-07 | シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー | ゲノム編集のための方法 |
| EP3165234B1 (de) | 2009-07-31 | 2019-04-03 | ethris GmbH | Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression |
| CA2770312A1 (en) * | 2009-08-11 | 2011-02-17 | Sangamo Biosciences, Inc. | Organisms homozygous for targeted modification |
| AU2010315166B2 (en) | 2009-11-04 | 2015-01-22 | FUJIFILM Cellular Dynamics, Inc. | Episomal reprogramming with chemicals |
| KR20120107088A (ko) | 2009-11-11 | 2012-09-28 | 샌포드-번햄 메디칼 리서치 인스티튜트 | ⅰＰＳ 세포들의 생산 및 조절 방법 및 그들의 조성물들 |
| ES2779048T3 (es) * | 2009-11-12 | 2020-08-13 | Technion Res & Dev Foundation | Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado |
| BR112012013875B8 (pt) | 2009-12-07 | 2020-06-23 | Person Anthony | método in vitro para reprogramar células somáticas humanas ou de outros mamíferos para células tronco pluripotentes induzidas (células ips ou ipscs) e composição |
| US20130189741A1 (en) | 2009-12-07 | 2013-07-25 | Cellscript, Inc. | Compositions and methods for reprogramming mammalian cells |
| WO2011072246A2 (en) | 2009-12-10 | 2011-06-16 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| US8557972B2 (en) | 2009-12-21 | 2013-10-15 | University Of Washington Through Its Center For Commercialization | Compositions and methods for transfection of RNA and controlled stabilization of transfected RNA |
| WO2011094738A1 (en) | 2010-02-01 | 2011-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced efficiency of induced pluripotent stem cell generation |
| WO2011110886A1 (en) | 2010-03-09 | 2011-09-15 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| WO2011130346A1 (en) * | 2010-04-13 | 2011-10-20 | Sigma-Aldrich Co. | Methods for generating endogenously tagged protein |
| WO2011130624A2 (en) * | 2010-04-16 | 2011-10-20 | Immune Disease Institute, Inc. | Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
| WO2011132799A1 (en) * | 2010-04-22 | 2011-10-27 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into skeletal muscle or skeletal muscle progenitor cells |
| WO2011139336A1 (en) * | 2010-04-26 | 2011-11-10 | Sangamo Biosciences, Inc. | Genome editing of a rosa locus using nucleases |
| CN102234627B (zh) * | 2010-04-30 | 2015-06-03 | 中国科学院广州生物医药与健康研究院 | 一种培养基添加剂及其应用 |
| WO2011140397A2 (en) | 2010-05-05 | 2011-11-10 | The Regents Of The University Of California Office Of The President | Stem cell defined media for xeno-free and feeder free conditions and uses thereof |
| US8048675B1 (en) | 2010-05-12 | 2011-11-01 | Ipierian, Inc. | Integration-free human induced pluripotent stem cells from blood |
| US20130145487A1 (en) | 2010-05-12 | 2013-06-06 | Cellectis | Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof |
| EP2571512B1 (en) | 2010-05-17 | 2017-08-23 | Sangamo BioSciences, Inc. | Novel dna-binding proteins and uses thereof |
| EP2392208B1 (en) | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| CN103180434A (zh) | 2010-08-05 | 2013-06-26 | 威斯康星校友研究基金会 | 用于人多能细胞培养的简化基础培养基 |
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| WO2012021632A2 (en) * | 2010-08-10 | 2012-02-16 | The Johns Hopkins University | Generation and use of pluripotent stem cells |
| US9447408B2 (en) | 2010-09-14 | 2016-09-20 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
| ES3005233T3 (en) | 2010-10-01 | 2025-03-14 | Modernatx Inc | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| EP2625278A1 (en) | 2010-10-08 | 2013-08-14 | Regents of the University of Minnesota | A method to increase gene targeting frequency |
| JP5888753B2 (ja) | 2010-11-04 | 2016-03-22 | 国立大学法人京都大学 | 効率的な人工多能性幹細胞の樹立方法 |
| EP2683812A4 (en) | 2011-03-07 | 2014-12-03 | Massachusetts Inst Technology | METHOD FOR CELL TRANSFECTION WITH NUCLEIC ACIDS |
| DE12722942T1 (de) | 2011-03-31 | 2021-09-30 | Modernatx, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
| US10086043B2 (en) | 2011-04-03 | 2018-10-02 | The General Hospital Corporation | Efficient protein expression in vivo using modified RNA (MOD-RNA) |
| WO2013003475A1 (en) | 2011-06-27 | 2013-01-03 | Cellscript, Inc. | Inhibition of innate immune response |
| CA2841165A1 (en) * | 2011-07-11 | 2013-01-17 | Cellular Dynamics International, Inc. | Methods for cell reprogramming and genome engineering |
| RU2648950C2 (ru) | 2011-10-03 | 2018-04-02 | Модерна Терапьютикс, Инк. | Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение |
| KR20250035015A (ko) | 2011-12-05 | 2025-03-11 | 팩터 바이오사이언스 인크. | 세포를 형질감염시키는 방법들 및 생성물들 |
| AU2012352180A1 (en) | 2011-12-16 | 2014-07-31 | Moderna Therapeutics, Inc. | Modified nucleoside, nucleotide, and nucleic acid compositions |
| WO2013096709A2 (en) | 2011-12-21 | 2013-06-27 | modeRNA Therapeutics | Methods of increasing the viability or longevity of an organ or organ explant |
| LT3144389T (lt) | 2011-12-30 | 2018-08-10 | Cellscript, Llc | In vitro susintetintos viengrandės rnr gavimas ir panaudojimas įvedimui į žinduolio ląsteles, siekiant sužadinti biologinį arba biocheminį poveikį |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| WO2013163296A1 (en) | 2012-04-24 | 2013-10-31 | The Brigham And Women's Hospital, Inc. | Generating pluripotent cells de novo |
| US10155929B2 (en) | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| US10119150B2 (en) | 2012-05-13 | 2018-11-06 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| EP3561054B1 (en) | 2012-05-13 | 2023-07-05 | Allele Biotechnology And Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna |
| ES3047667T3 (en) | 2013-02-22 | 2025-12-04 | Univ Leland Stanford Junior | Methods relating to telomere extension |
| EP2918275B1 (en) | 2013-12-13 | 2016-05-18 | Moderna Therapeutics, Inc. | Alternative nucleic acid molecules and uses thereof |
| EP3328373B1 (en) * | 2015-07-27 | 2023-06-07 | Kimberly-Clark Worldwide, Inc. | Disinfectant composition with rapid antiviral efficacy |
-
2012
- 2012-12-05 KR KR1020257006012A patent/KR20250035015A/ko active Pending
- 2012-12-05 KR KR1020247009226A patent/KR20240039237A/ko not_active Ceased
- 2012-12-05 CN CN202010626574.5A patent/CN111893140A/zh active Pending
- 2012-12-05 KR KR1020217034975A patent/KR20210134808A/ko not_active Ceased
- 2012-12-05 CN CN201280068223.0A patent/CN104080482B/zh active Active
- 2012-12-05 MX MX2014006663A patent/MX354995B/es active IP Right Grant
- 2012-12-05 EP EP12813595.1A patent/EP2788033B1/en active Active
- 2012-12-05 DK DK17170810.0T patent/DK3260140T3/da active
- 2012-12-05 AU AU2012347919A patent/AU2012347919B2/en active Active
- 2012-12-05 RU RU2014127505A patent/RU2624139C2/ru active
- 2012-12-05 KR KR1020207036814A patent/KR102320571B1/ko active Active
- 2012-12-05 CA CA2858148A patent/CA2858148C/en active Active
- 2012-12-05 KR KR1020147018569A patent/KR102196339B1/ko active Active
- 2012-12-05 EP EP17170810.0A patent/EP3260140B1/en active Active
- 2012-12-05 JP JP2014546024A patent/JP6073916B2/ja active Active
- 2012-12-05 WO PCT/US2012/067966 patent/WO2013086008A1/en not_active Ceased
- 2012-12-05 EP EP20211670.3A patent/EP3835420A1/en active Pending
- 2012-12-05 MX MX2018003987A patent/MX382822B/es unknown
- 2012-12-05 RU RU2017118312A patent/RU2691027C2/ru not_active IP Right Cessation
- 2012-12-05 BR BR112014013664-5A patent/BR112014013664A2/pt not_active Application Discontinuation
- 2012-12-05 CA CA3188654A patent/CA3188654A1/en active Pending
-
2014
- 2014-06-04 MX MX2021000211A patent/MX2021000211A/es unknown
- 2014-06-04 US US14/296,220 patent/US9422577B2/en active Active
- 2014-06-04 MX MX2021000209A patent/MX2021000209A/es unknown
- 2014-06-04 MX MX2021000210A patent/MX2021000210A/es unknown
-
2015
- 2015-02-20 US US14/627,666 patent/US20150167019A1/en not_active Abandoned
-
2016
- 2016-07-11 US US15/207,167 patent/US9605277B2/en active Active
- 2016-07-28 US US15/222,453 patent/US9605278B2/en active Active
- 2016-10-31 JP JP2016213019A patent/JP6294944B2/ja active Active
- 2016-12-19 AU AU2016277545A patent/AU2016277545B2/en active Active
-
2017
- 2017-02-10 US US15/429,795 patent/US20170152483A1/en not_active Abandoned
- 2017-02-10 US US15/429,798 patent/US20170151285A1/en not_active Abandoned
- 2017-09-08 AU AU2017225124A patent/AU2017225124B2/en active Active
-
2018
- 2018-04-10 RU RU2018112719A patent/RU2018112719A/ru unknown
-
2019
- 2019-05-02 US US16/402,175 patent/US10472611B2/en active Active
- 2019-05-24 AU AU2019203662A patent/AU2019203662B2/en active Active
- 2019-09-11 US US16/567,059 patent/US11466293B2/en active Active
-
2020
- 2020-01-30 US US16/776,765 patent/US10662410B1/en active Active
- 2020-04-24 US US16/857,894 patent/US10829738B2/en active Active
- 2020-04-27 AU AU2020202780A patent/AU2020202780B2/en active Active
- 2020-05-07 US US16/869,232 patent/US10982229B2/en active Active
- 2020-06-26 US US16/913,315 patent/US11708586B2/en active Active
- 2020-06-26 US US16/913,306 patent/US11692203B2/en active Active
-
2022
- 2022-06-29 AU AU2022204659A patent/AU2022204659B2/en active Active
- 2022-08-05 US US17/817,966 patent/US12227757B2/en active Active
- 2022-08-22 US US17/821,298 patent/US20230242943A1/en not_active Abandoned
- 2022-08-31 AU AU2022224788A patent/AU2022224788B2/en active Active
-
2023
- 2023-06-09 US US18/332,621 patent/US12391961B2/en active Active
- 2023-06-09 US US18/332,620 patent/US20230304044A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015506673A5 (cg-RX-API-DMAC7.html) | ||
| RU2018112719A (ru) | Способы и препараты для трансфекции клеток | |
| JP2018115207A5 (cg-RX-API-DMAC7.html) | ||
| Attwood et al. | iPS-cell technology and the problem of genetic instability—Can it ever be safe for clinical use? | |
| JP2016500260A5 (cg-RX-API-DMAC7.html) | ||
| MacArthur et al. | Generation of human‐induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder‐free or xeno‐free conditions | |
| JP2015516812A5 (cg-RX-API-DMAC7.html) | ||
| JP2011529330A5 (cg-RX-API-DMAC7.html) | ||
| JP2013544069A5 (cg-RX-API-DMAC7.html) | ||
| JP2010158171A5 (cg-RX-API-DMAC7.html) | ||
| JP2012518988A5 (cg-RX-API-DMAC7.html) | ||
| JP2013517758A5 (cg-RX-API-DMAC7.html) | ||
| JP2015525065A5 (cg-RX-API-DMAC7.html) | ||
| Sommer et al. | The evolving field of induced pluripotency: recent progress and future challenges | |
| JP2018113985A5 (cg-RX-API-DMAC7.html) | ||
| JP2011525793A5 (cg-RX-API-DMAC7.html) | ||
| MX2019002498A (es) | Metodos y productos para la expresion de proteinas en celulas. | |
| CN102093981B (zh) | 一种高效诱导人类体细胞重编程为多潜能干细胞的方法 | |
| Wang et al. | A transcriptional roadmap to the induction of pluripotency in somatic cells | |
| JP2014513983A5 (cg-RX-API-DMAC7.html) | ||
| IL292650A (en) | Chimeric antigen receptor T cells target il13ra2 | |
| RU2012101874A (ru) | Получение индуцированных плюрипотентных стволовых клеток из пуповинной крови | |
| WO2009077134A3 (en) | Use of rna for reprogramming somatic cells | |
| RU2020105656A (ru) | Нетоксичные векторы на основе впг для применений в эффективной доставке генов и комплементирующие клетки для их продуцирования | |
| JP2011068660A5 (cg-RX-API-DMAC7.html) |